Physicians from around the world share insights and tips on brain health
Press Releases
81% of U.S. physicians and 62% of doctors worldwide believe a second wave of COVID-19 is likely to occur
Survey Shows Nearly Half (44%) of U.S. Doctors Believe Fewer Patients will be Infected during a Second Wave Compared to the First
Sermo’s COVID-19 Real Time Barometer survey shows physicians are navigating treatment landscape without a unified approach for the universal COVID-19 pandemic
Global Treatment Patterns Reveal Steady Decline in Hydroxychloroquine Usage and Consistent Increase in Remdesivir Usage in ICU Setting
Global survey finds nearly half of physicians who have seen children with suspected Pediatric Multisystem Inflammatory Syndrome have seen these cases in past week
Survey Data and Experiences in Other Countries Suggest United States Could See Surge in Cases of Pediatric Disease Linked to COVID-19
Non-invasive oxygen therapies delay or prevent intubation but are believed to aerosolize coronavirus by 80% of global physicians treating COVID-19 in hospitals
34% of COVID-19 treating physicians still believe ventilators are used too rapidly according to their hospital protocols
Sermo reports: Worldwide Remdesivir usage grows, but 67% of doctors believe Remdesivir would be most effective administered earlier, before patients become severely ill
75% of global physicians treating COVID-19 rate Remdesivir with low to moderate efficacy and find current Remdesivir indication confusing
Plasma perceived as most effective treatment for the last five weeks
Sermo reports: 85% of worldwide physicians see false negative test results with COVID-19 Patients and 9% have seen at least one case of re-infection
As States Ease Up on Restrictions, Accurate Testing and Tracing are Critical to Stopping Disease Spread and Virus Reinfection
Sermo reports: COVID-19 treatment trends over 6 weeks and 33,700 interviews: Usage, efficacy and safety perceptions of most-used therapies
High demand for Plasma and Remdesivir
Currently, 55% of global physicians use Hydroxychloroquine, 24% use Tocilizumab, 21% use Remdesivir, 17% use Plasma
Sermo reports: 50% of highly experienced COVID treaters believe COVID-19 is more of an “oxygen failure” disease vs. a respiratory disease leading to ARDS; 48% believe ventilators used too rapidly
Physicians share insights on potential new clinical guidelines, ventilation protocol changes and alternative oxygen therapies
Sermo reports: 58% of US physicians report HCPs testing positive for COVID-19 in their hospital/clinic; Korea, China, Japan report the least COVID-19 infections among colleagues
Florida, Texas, Virginia, and Ohio Have Seen Sharpest Increase In Physicians Reporting Infections Among HCP Colleagues; Globally, Russia, Mexico, Brazil & Great Britain Have Seen Sharpest Increase
Sermo reports: Only 52% of US physicians say the country has passed or reached outbreak peak; 73% recommend keeping restrictions
Majority of Physicians in Many COVID-19 Hotspots Including Korea, Spain, China and Italy Believe Their Countries Have Passed or Reached Outbreak Peak
Kentucky is the Only US State Where More Than 50% of Physicians Recommend Lifting Restrictions Within 2 Weeks
Sermo reports jury is still out on Remdesivir; 31% of physicians who have used Remdesivir rate it as highly effective; 31% rate it with low effectiveness; 38% rate it as somewhere in the middle
Plasma rated as most safe and effective treatment; 57% of physicians who have used Plasma rate it as highly effective; 60% rate it as safe
Efficacy of treatments as seen by 430 COVID Supertreaters (physicians who’ve treated 20+ COVID patients)